Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend Overview and Price Movement

Strides Pharma Science Ltd (NSE: 688428) currently trades at ₹1,095.85, marginally up 0.24% from the previous close of ₹1,093.25. The stock’s intraday range on 2 Jul 2026 spanned ₹1,088.65 to ₹1,118.70, indicating moderate volatility within a relatively tight band. The 52-week high stands at ₹1,231.45, while the low is ₹769.60, underscoring a significant recovery and upward trajectory over the past year.

The technical trend has shifted from bullish to mildly bullish, signalling a tempering of the prior strong upward momentum. This subtle change suggests that while the stock retains positive bias, investors should monitor for potential consolidation or pullback phases.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator presents a mixed picture. On a weekly basis, the MACD is mildly bearish, hinting at a short-term weakening in momentum. Conversely, the monthly MACD remains bullish, reflecting sustained longer-term strength. This divergence between weekly and monthly MACD readings suggests that while short-term momentum may be softening, the broader trend remains intact.

Complementing this, the Know Sure Thing (KST) oscillator is bullish on the weekly chart but mildly bearish monthly, reinforcing the notion of short-term caution amid longer-term optimism.

Relative Strength Index (RSI) and Bollinger Bands

The RSI readings further complicate the technical outlook. The weekly RSI shows no clear signal, indicating neither overbought nor oversold conditions in the short term. However, the monthly RSI is bearish, suggesting that the stock may be approaching overextended territory on a longer timeframe, which could precede a corrective phase.

In contrast, Bollinger Bands are bullish on both weekly and monthly charts, signalling that price volatility remains supportive of upward movement. The stock price currently trades near the upper Bollinger Band, which often acts as a resistance zone but also confirms strong price momentum.

Moving Averages and Volume-Based Indicators

Daily moving averages remain bullish, indicating that the stock price is trading above key short-term averages such as the 20-day and 50-day moving averages. This supports the view that the immediate trend is positive and that buyers continue to exert control.

However, volume-based indicators like On-Balance Volume (OBV) show no discernible trend on both weekly and monthly charts. The lack of volume confirmation may imply that price movements are not strongly supported by trading activity, which could limit the sustainability of recent gains.

Dow Theory and Broader Market Context

According to Dow Theory, there is no clear trend on either weekly or monthly timeframes for Strides Pharma Science Ltd. This absence of confirmation from a classical market theory perspective suggests that the stock may be in a phase of indecision or transition.

Comparing Strides Pharma’s returns with the Sensex provides additional context. Year-to-date, Strides Pharma has delivered a robust 21.44% return, significantly outperforming the Sensex’s negative 9.74% return. Over one year, the stock’s gain of 26.75% contrasts sharply with the Sensex’s decline of 8.09%. Even over three and five years, Strides Pharma’s returns of 430.30% and 199.38% respectively dwarf the Sensex’s 18.86% and 47.03%, highlighting the company’s strong long-term performance despite recent technical caution.

Mojo Score and Analyst Ratings

MarketsMOJO assigns Strides Pharma a Mojo Score of 56.0 with a current Mojo Grade of Hold, upgraded from a previous Sell rating on 6 Apr 2026. This upgrade reflects improved technical and fundamental assessments, though the Hold rating indicates that investors should maintain a cautious stance rather than aggressively accumulate shares at this stage.

The company is classified as a small-cap within the Pharmaceuticals & Biotechnology sector, which often entails higher volatility but also greater growth potential compared to large-cap peers.

Investor Implications and Outlook

Investors analysing Strides Pharma Science Ltd should weigh the mixed technical signals carefully. The mildly bullish trend and daily moving average support suggest that the stock retains upside potential in the near term. However, the mildly bearish weekly MACD, bearish monthly RSI, and lack of volume confirmation counsel prudence.

Given the stock’s strong long-term outperformance relative to the Sensex and the recent upgrade in Mojo Grade, it remains an attractive candidate for investors with a medium to long-term horizon. Short-term traders, however, may prefer to wait for clearer confirmation of trend direction, especially considering the absence of a definitive Dow Theory trend and the divergence among momentum indicators.

Overall, Strides Pharma Science Ltd exemplifies a stock at a technical crossroads, where momentum is moderating but underlying fundamentals and sector dynamics continue to support a cautiously optimistic stance.

Summary of Key Technical Metrics:

• Current Price: ₹1,095.85
• 52-Week Range: ₹769.60 – ₹1,231.45
• Technical Trend: Mildly Bullish (from Bullish)
• MACD: Weekly Mildly Bearish, Monthly Bullish
• RSI: Weekly Neutral, Monthly Bearish
• Bollinger Bands: Weekly & Monthly Bullish
• Moving Averages: Daily Bullish
• KST: Weekly Bullish, Monthly Mildly Bearish
• Dow Theory: No Trend (Weekly & Monthly)
• OBV: No Trend (Weekly & Monthly)
• Mojo Score: 56.0 (Hold, upgraded from Sell)

Investors should continue to monitor these indicators closely for signs of trend confirmation or reversal, particularly as the stock approaches key resistance levels near its 52-week high.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →